September 12, 2012 |
Kathy Bates has beaten cancer yet again, she revealed Wednesday. "Hey All, sorry for the long silence," she said in a two-part Twitter message. "I was diagnosed with breast cancer 2 months ago & am recovering from a double mastectomy. ... I don't miss my breasts as much as I miss Harry's Law. ;-) Thanks for all the sweet tweets. Y'all kept me going. " The "Titanic" actress was diagnosed with ovarian cancer in 2003, an experience she discussed in the video above, for the Ovarian Cancer National Alliance.
January 6, 2012 |
In a study suggesting that red wine might be the next big thing in breast cancer prevention, a study has found that women who drank just under two servings of red wine daily experienced hormonal changes that mimic the effects of a drug used to prevent malignant breast tumors from coming back. The study, published Friday in the Journal of Women's Health, found that consuming the same amount of white wine did not have the same effect in premenopausal women participating in the study.
February 2, 2012 |
The long-debunked idea that abortions can contribute to breast cancer is reappearing amid the outpouring of comments this week on Susan G. Komen for the Cure's decision to stop funding Planned Parenthood breast-health programs. Here's one comment on Komen's Facebook page: "Also! Breast cancer is linked to abortions!!! More and more studied are pointing to abortions for a huge risk factor for BC, why should SGK support something that raises the chances of what they wasn't destroyed?
July 26, 2011 |
Women with early-stage breast cancer have plenty of procedures and treatments to deal with. So it may come as welcome news that a large clinical trial has found no reason for doctors to perform two tests that were thought to help predict patient survival. Writing in the Journal of the American Medical Assn., the researchers say that the test results are meaningless. The tests in question involve looking for micrometastasis - microscopic evidence of a breast tumor's spread - in sentinel lymph nodes and in bone marrow.
March 13, 2013 |
These days, thanks to advances in treatment and detection, millions of women survive breast cancer. But surviving the disease doesn't necessarily mean the entire battle is over, a population-based study of breast cancer survivors in Sweden and Denmark, published Wednesday in the New England Journal of Medicine , seems to suggest. Assessing a total of 2,168 women whose breast cancer was treated with radiation therapy between 1958 and 2001, a team of researchers found that women's chances of having a major coronary event - a heart attack, bypass surgery or heart disease death - rose in proportion with the radiation dose they received, even at the lower doses of radiation delivered in newer treatments.
December 10, 2010 |
The breast cancer drug pertuzumab when added to Herceptin improved the treatment of women with early-stage, HER-2 positive breast cancer, researchers reported Friday at the annual meeting of the San Antonio Breast Cancer Symposium . Pertuzumab is an experimental monoclonal antibody. In the study, 417 women received monoclonal antibody drug therapy before having surgery to remove the tumor. Some women also underwent chemotherapy. Adding pertuzumab to Herceptin -- which is also known by the generic name trastuzumab -- along with the chemotherapy drug docetaxel led to a tumor eradication rate of 46%. That is 50% better than the tumor eradication rate achieved with the standard therapy of docetaxel and Herceptin combined, said the authors of the paper, from the National Cancer Institute in Milan, Italy.